KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Gains from Investment Securities: 2009-2024

Historic Gains from Investment Securities for Bausch Health Companies (BHC) over the last 16 years, with Dec 2024 value amounting to $26.0 million.

  • Bausch Health Companies' Gains from Investment Securities changed negligibly% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.0 million, marking a year-over-year increase of 12.50%. This contributed to the annual value of $26.0 million for FY2024, which is 8.33% up from last year.
  • Bausch Health Companies' Gains from Investment Securities amounted to $26.0 million in FY2024, which was up 8.33% from $24.0 million recorded in FY2023.
  • In the past 5 years, Bausch Health Companies' Gains from Investment Securities ranged from a high of $52.0 million in FY2021 and a low of $24.0 million during FY2023.
  • For the 3-year period, Bausch Health Companies' Gains from Investment Securities averaged around $27.0 million, with its median value being $26.0 million (2024).
  • As far as peak fluctuations go, Bausch Health Companies' Gains from Investment Securities spiked by 73.33% in 2021, and later plummeted by 40.38% in 2022.
  • Bausch Health Companies' Gains from Investment Securities (Yearly) stood at $30.0 million in 2020, then surged by 73.33% to $52.0 million in 2021, then slumped by 40.38% to $31.0 million in 2022, then decreased by 22.58% to $24.0 million in 2023, then rose by 8.33% to $26.0 million in 2024.